CLS: ClearPoint Neuro receives 510(k) clearance for its Prism Bone Anchor Accessory - Redeye

Redeye endorses that CLS’ partner, ClearPoint Neuro, has received FDA (510k) clearance for its Prism Bone Anchor Accessory. Furthermore, we are positive that the limited market launch of the ClearPoint Prism Neuro Laser Therapy System will start according to plan, with a full market release expected during the second half of 2024.

Länk till analysen i sin helhet: https://www.redeye.se/research/1001483/cls-clearpoint-neuro-receives-510k-clearance-for-its-prism-bone-anchor-accessory?utm_source=finwire&utm_medium=RSS